Central Bank & Trust CO Novartis Ag Transaction History

Central Bank & Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 20, 2021	SELL	$83.5 - $98.47 $3,924 - $4,628	-47 Reduced 40.17%	70 $6,000
Q2 2020 Jul 15, 2020	SELL	$80.93 - $91.1 $2,670 - $3,006	-33 Reduced 22.0%	117 $10,000
Q1 2020 Apr 14, 2020	BUY	$70.67 - $99.01 $2,332 - $3,267	33 Added 28.21%	150 $14,000
Q3 2019 Oct 23, 2019	SELL	$85.54 - $94.26 $2,822 - $3,110	-33 Reduced 22.0%	117 $10,000
Q3 2018 Nov 23, 2018	SELL	$66.94 - $77.43 $4,351 - $5,032	-65 Reduced 30.23%	150 $13,000
Q3 2017 Oct 13, 2017	BUY	$74.14 - $77.27 $15,940 - $16,613	215	215 $18,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.